*The following content is generated by AI and is for reference only.
<h3>Overview</h3>
<p>Niraparib API is a potent small-molecule PARP inhibitor synthesized via multi-step organic catalysis. Its molecular formula is <strong>C<sub>25</sub>H<sub>24</sub>F<sub>3</sub>N<sub>5</sub>O<sub>2</sub>S</strong> (CAS No. <strong>910468-67-6</strong>), primarily utilized in pharmaceutical R&D for oncology research.</p>
<h3>Application</h3>
<ul>
<li><strong>Oncology Research:</strong> Investigating synthetic lethality in BRCA-deficient tumors.</li>
<li><strong>Drug Discovery:</strong> Screening compound libraries for DNA repair pathway modulation.</li>
<li><strong>In Vitro Assays:</strong> Validating PARP enzymatic activity inhibition mechanisms.</li>
</ul>
<h3>Precautions</h3>
<p>Strictly limited to laboratory use; not for human consumption. Store at -20°C under inert atmosphere. Personnel must utilize appropriate PPE due to potential cytotoxicity and reproductive hazards associated with the active moiety.</p>